• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

SCORPIO

Sars-COV-2 vaccine ResPonse In Obesity

  • Home
  • Researchers
  • Visit Info
    • Trial locations
    • COVID-19
  • Funding
  • News
  • Contact us
Illustration of COVID particles

Funding

You are here: Home / Funding

Thanks to UKRI for funding this COVID-19 vaccine research project
SCORPIO was one of five nationally selected studies that investigate optimal use of vaccines in vulnerable patient groups. This funding seeks to underpin how best to use vaccines for protection from COVID-19 infection. It is a multi-centre study, involving researchers from Cambridge University – the Wellcome-MRC Institute of Metabolic Sciences, Department of Medicine Cambridge Infectious Diseases and MRC Toxicology Unit, in collaboration with the Babraham Institute and King’s College Hospital, London.

More information on the other four COVID 19 vaccine research projects funded can be found here.

Contact Us

Email: genetics.ofobesity@nhs.net

University of Cambridge Metabolic Research Laboratories
Level 4, Institute of Metabolic Science
Box 289, Addenbrooke’s Hospital
Cambridge, CB2 0QQ

Copyright © 2022 · SCORPIO · All Rights Reserved · Hosted by CSCS

Back to top